Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (IS:ONCSM) — Market Cap & Net Worth
Market Cap & Net Worth: Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM)
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (IS:ONCSM) has a market capitalization of $132.48 Million (TL5.91 Billion) as of August 7, 2026. Listed on the IS stock exchange, this Turkey-based company holds position #18130 globally and #241 in its home market, demonstrating a -9.65% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s stock price TL248.00 by its total outstanding shares 23850000 (23.85 Million). See ONCSM capital expenditure intensity to understand how much of operating cash flow is reinvested back into capital assets.
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Market Cap History: 2023 to 2026
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s market capitalization history from 2023 to 2026. Data shows growth from $79.91 Million to $132.48 Million (104.22% CAGR).
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.33x
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s market cap is 0.33 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $79.91 Million | $240.51 Million | -$79.81 Million | 0.33x | N/A |
Competitor Companies of ONCSM by Market Capitalization
Companies near Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. in the global market cap rankings as of August 7, 2026.
Key companies related to Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #117 globally with a market cap of $183.82 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #184 globally with a market cap of $128.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #240 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #117 | Abbott Laboratories | NYSE:ABT | $183.82 Billion | $105.71 |
| #184 | Stryker Corporation | NYSE:SYK | $128.98 Billion | $337.03 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #240 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.99 |
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Historical Marketcap From 2023 to 2026
Between 2023 and today, Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s market cap moved from $79.91 Million to $ 132.48 Million, with a yearly change of 104.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | TL132.48 Million | -5.70% |
| 2025 | TL140.49 Million | +147.88% |
| 2024 | TL56.68 Million | -29.08% |
| 2023 | TL79.91 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 6th, 2026 the market cap of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $132.48 Million USD |
| MoneyControl | $132.48 Million USD |
| MarketWatch | $132.48 Million USD |
| marketcap.company | $132.48 Million USD |
| Reuters | $132.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi manufactures and sells chemotherapy drug preparation kits, medical devices, and test kits in Turkey. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system, chemotherapy drugs, cephalosporins, penicillins,… Read more